Evaluation of the Clinical use of Metformin or Pioglitazone in Combination with Meloxicam in Patients with Knee Osteoarthritis; using Knee Injury and Osteoarthritis outcome Score
Osteoarthritis is the most prevalent arthritic disease and a leading cause of disability. The pathogenesis of osteoarthritis involves multiple etiologies, including variable degree of synovial inflammation. Metformin and pioglitazone could potentially reduce the levels and activity of inflammatory m...
Saved in:
Main Authors: | Mohammed M. Mohammed (Author), Kassim J. Al-Shamma (Author), Nizar A. Jassim (Author) |
---|---|
Format: | Book |
Published: |
College of Pharmacy University of Baghdad,
2017-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of the Clinical use of Metformin or Pioglitazone in Combination with Meloxicam in Patients with Knee Osteoarthritis; using Knee Injury and Osteoarthritis outcome Score
by: Mohammed M. Mohammed, et al.
Published: (2017) -
Curcumin as adjuvant therapy to Meloxicam in treatment of patients with knee Osteoarthritis; Evaluation of antioxidant activity
by: Maiss Saadi Baqer, et al.
Published: (2020) -
Commentary: Scoring Flaw in the Persian Version of Knee Injury and Osteoarthritis Outcome Score: A comment on "Validation of a Persian-version of Knee injury and Osteoarthritis Outcome Score (KOOS) in Iranians with knee injuries. Osteoarthritis Cartilage 2008 Oct;16(10):1178-82"
by: Zahra Sadat Rezaeian
Published: (2021) -
The simplified Chinese version of the Knee Injury and Osteoarthritis Outcomes Score (KOOS) in individuals with knee osteoarthritis for mainland China: the study of reliability and validity
by: Liying Yang, et al.
Published: (2023) -
Cross-Cultural Adaptation and Validation of the Hong Kong Version of the Knee Injury and Osteoarthritis Outcome Score (HK-KOOS) for Patients with Knee Osteoarthritis
by: Andy S. K. Cheng, et al.
Published: (2019)